Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
Public ClinicalTrials.gov record NCT02508649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Randomised, Placebo-Controlled, Phase 2b/3 Adaptive Clinical Trial Investigating the Efficacy and Safety of Selepressin as Treatment for Patients With Vasopressor-dependent Septic Shock
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a double-blind, randomised, placebo-controlled, two-part adaptive clinical trial. The trial is designed to investigate the efficacy and safety of multiple dosing regimens of selepressin and to confirm the efficacy and safety of one dosing regimen in treatment of adult patients with septic shock requiring vasopressor.
Study identification
- NCT ID
- NCT02508649
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 868 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2015
- Primary completion
- Oct 2, 2017
- Completion
- Feb 25, 2018
- Last update posted
- Apr 5, 2021
2015 – 2018
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Memorial Hospital | Colorado Springs | Colorado | 80909 | — |
| Eastern Idaho Regional Medical Center | Idaho Falls | Idaho | 83404 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Northshore University Healthsystem Research Institute | Evanston | Illinois | 60201 | — |
| Stormont Vail Health Care | Topeka | Kansas | 66604 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | — |
| Henry Ford Hospital | Detroit | Michigan | — | — |
| HealthPartners Speciality Clinics | Saint Paul | Minnesota | 55101 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Cooper University Hospital | Camden | New Jersey | 08103 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| Ohio State University | Columbus | Ohio | 43210-1252 | — |
| Remington Davis Inc | Columbus | Ohio | 43215 | — |
| St Vincent Mercy Medical Center | Toledo | Ohio | 43608 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | — | — |
| Temple University Hospital | Philadelphia | Pennsylvania | — | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02508649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2021 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02508649 live on ClinicalTrials.gov.